iTeos Therapeutics to raise $120 million via registered direct offering

iTeos Therapeutics Inc (NASDAQ: ITOS) is up 30% today after announcing plans of a registered direct offering.  iTeos Therapeutics stock pops on Q1 earnings The biotechnology company will sell a total of 1,142,857 shares at $17.50 each which translates to a 44% premium on its previous close.  The offering will also include...